PeterAAntonMD

Gastroenterology • Los Angeles, CA

Professor, Medicine, UCLA School of Medicine

Join to view full profile

Dr. Anton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anton's full profile

Already have an account?

Office
200 Medical Plz 365c
Los Angeles, CA 90095
Phone+1 310-825-1597

Fax+1 310-206-3607

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1986 - 1990
Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
Case Western Reserve University School of MedicineClass of 1983

Certifications & Licensure

CA State Medical License 1986 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines
Completed
Phase 1
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients Start of enrollment: 1999 Oct 01
Completed
Phase 1
A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials
Completed
Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm Start of enrollment: 2006 Jun 01
Completed
Phase 1
Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability Start of enrollment: 2006 Sep 01
Completed
Optimization of a Tenofovir Enema for HIV Prevention Start of enrollment: 2016 Oct 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Acceptability of a rectal microbicide douche for HIV prevention: a mixed-methods analysis of a first-in-human formulation pilot study.
Rebecca Giguere, Iván C Balán, Cody Lentz, Curtis Dolezal, Alex Carballo-Diéguez
Sexually Transmitted Infections. 2024-09-05
2 citations
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01).
Ethel D Weld, Ian McGowan, Peter Anton, Edward J Fuchs, Ken Ho
The Journal of Infectious Diseases. 2024-04-12
4 citations
A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study).
Ian McGowan, Sylvain Chawki, Craig W. Hendrix, Peter A. Anton, Mark A. Marzinke
AIDS Research and Human Retroviruses. 2021-09-14

Journal Articles

Safety and Pharmacokinetics of Single, Dual, and Triple Antiretroviral Drug Formulations Delivered by Pod-Intravaginal Rings Designed for HIV-1 Prevention: A Phase I T...
Peter A Anton, Trevelyn J Olive, Mark A Marzinke, Rochelle K Rosen, Craig W Hendrix, Kathleen L Vincent, PLoS One
Does Per‐Act HIV‐1 Transmission Risk Through Anal Sex Vary by Gender? An Updated Systematic Review and Meta‐Analysis
Peter Anton, Ian McGowan, American Journal of Reproductive Immunology
Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1
Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases

Grant Support

Mucosal Immunology CoreNational Institute Of Allergy And Infectious Diseases2008–2012
Regulatory Compliance And Human Subjects SafetyNational Institute Of Allergy And Infectious Diseases2009
Exploratory Human Trials Of Rectal MicrobicidesNational Institute Of Allergy And Infectious Diseases2009
Data Management And BiostatisticsNational Institute Of Allergy And Infectious Diseases2009
AdministrativeNational Institute Of Allergy And Infectious Diseases2009
Microbicide Development Program (MDP)National Institute Of Allergy And Infectious Diseases2004–2009
Core A - AdministrativeNational Institute Of Allergy And Infectious Diseases2006
Compartment-Specific Topical Microbicide FormulationsNational Institute Of Allergy And Infectious Diseases2006
Role Of Site Of Immunization In Eliciting Mucosal Immunity -Alvac HIV (Vcp205National Center For Research Resources2005
A Novel Pre-Clinical Mucosal Immunization Against HIV-1: HIV Seronegative PARNational Center For Research Resources2005
Novel Pre-Clinical Mucosal Immunization Against HIV-1:National Center For Research Resources2004
Role Of Immunization Site In Eliciting Mucosal ImmunityNational Institute Of Allergy And Infectious Diseases2001–2004
Impact Of Co-Receptor And HIV Viral Burden On Gut MucosaNational Institute Of Allergy And Infectious Diseases2000–2004
Core--Mucosal ImmunityNational Institute Of Allergy And Infectious Diseases1998–2002
Neuroimmunomodulation In Human Gut MucosaNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993

Other Languages

Spanish

PeterAAntonMD

Dr. Anton is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Grant Support

Other Languages

Viewing the full profile is available to verified healthcare professionals only.